Piper Jaffray
Piper Jaffray is a client-focused, middle market investment bank and institutional securities firm founded in 1895 and based in Minneapolis, Minnesota.
Its Investment Banking activities include raising capital through equity and debt financings for corporate clients; providing financial advisory services relating to mergers and acquisitions to consumer, financial institutions, health care, technology, alternative energy, business services, and industrial growth sectors; underwriting debt issuances for government and non-profit clients; and providing financial advisory and interest rate risk management services.
The company's equity and fixed income institutional sales and trading activities include equity and fixed income advisory and trade execution services for public and private corporations, public entities, non-profit clients, and institutional investors.
View Older Stories View More Recent Stories
-
Piper Jaffray Initiates Coverage on Convio, Inc. (CNVO) with an Overweight; Nonprofit Cloud Computing Market Leader
-
Piper Jaffray Initiates Coverage on Alpha and Omega Semiconductor (AOSL); Emerging Power Management Player
-
China New Borun (BORN) Now Sees IPO Price of $8 - $9
-
Tornier N.V. (TRNX) Files $205M IPO
-
New York & Co. (NWY) Updates Q2 Outlook: Sees Loss Widening from Prior Views
-
Brown Shoe (BWS) Announces 16.9% Increase in Sales for May
-
Piper Jaffray Initiates Coverage on Dun & Bradstreet (DNB) with a Neutral; Storied Company, Wrong Time in Cycle
-
Piper Jaffray Maintains a 'Neutral' on Research In Motion (RIMM); Strong International Sales, CDMA Bold Sell-In Should Result in Solid May Qtr.
-
Notable Analyst Rating Changes 06/04: JOYG, MRK, ORCL, SGMS Upgraded; INFA, HYC, NLC, STP Downgraded
-
Piper Jaffray Reiterates an 'Overweight' Rating on Cyberonics (CYBX); Updates Model for FQ4-10
-
Piper Jaffray Initiates Coverage on Varian Medical (VAR) with an Overweight; Market Leader Now at the Technology Forefront
-
Ulta (ULTA) Files 9.76M Common Offering for Selling Shareholders
-
Piper Jaffray Upgrades Carmike Cinemas (CKEC) to Overweight; Valuation Call
-
Higher One Holdings (ONE) Sees IPO Price of $15-$17
-
Shares of Codexis (CDXS) are Trading 3.7% Higher; Piper & RBC Initiate Coverage
-
Notable Analyst Rating Changes 06/01: LVS, GENZ, V, CPT Upgraded; CNK, BEAT, GLW, AEO Downgraded
-
Piper Jaffray Initiates Coverage on Codexis (CDXS) with a Neutral; Timing Risk Balances Exciting Industrial Biotech Story
-
Piper Jaffray Initiates Coverage on Mitel Networks (MITL) with an Overweight; Large Upgrade Opportunity Awaits
-
Piper Jaffray Initiates Coverage on DynaVox Inc. (DVOX) with an Overweight; Giving Voice to a New Growth Stock
-
Piper Jaffray Maintains an 'Overweight' on Apple, Inc. (AAPL); Raising CY10 iPad Estimates
-
GenMark Diagnostics (GNMK) Prices 4.6M IPO at $6.00/Share
-
Unusual 11 Mid-Day Movers 05/28: JTX, CKXE, SEED, XIN, TWER, ANX Up; DJSP, BCSI, UVV, HAFC, SURW Down
-
Notable Analyst Rating Changes 05/28: OVTI, WFC, TTWO, SEED Upgraded; BCSI, JASO, DB Downgraded
-
Morning Movers 5/28: CKXE, HEV, SEED, NTZ, JTX Higher; BCSI Lower
-
Blue Coat Systems (BCSI) Delivers in Q4, But Softening European Demand Slams Shares
-
Piper Jaffray Maintains an 'Overweight' on Terremark Worldwide (TMRK); Raises PT & Estimates
-
Piper Jaffray Upgrades Cabela's Inc. (CAB) Based on Improving Charge-offs and NICS Data
-
Piper Jaffray Downgrades Blue Coat Systems (BCSI) to Neutral; Fall-Off in European Demand Drives Cautious Guide
-
American Eagle Outfitters (AEO) Hits Fresh 52-Wk Low; UBS Expects Revised Comp Estimates From Peers
-
Piper Jaffray Initiates Coverage on Chart Industries (GTLS), Citing Attractively Valuation; Shares Jump
-
Notable Analyst Rating Changes 05/27: MSFT, BP, LVS PAY Upgraded; NE, AEO, UNP, CSX Downgraded
-
Piper Jaffray Initiates Coverage on Chart Industries (GTLS) with an Overweight; Global Initiatives Provide Long-Term Growth Catalysts
-
Piper Jaffray Downgrades American Eagle (AEO) to Neutral; Recovery Timeline Extended; Lowering Estimates & PT
-
Anadys Pharma (ANDS) Announces $12.5M Registered Direct Offering
-
Vitamin Shoppe (VSI) Closes Secondary Offering
-
UQM Technologies (UQM) Shares Drop Almost 12% After Earnings Report, Piper Jaffray Downgrade
-
Neurocrine Biosciences (NBIX) Jumps 50% On Positive Trial Data
-
Piper Jaffray Trims Price Target On Guess? (GES), But Maintains Bullish View
-
Piper Jaffray Upgrades Neurocrine Biosciences (NBIX) to Overweight; Daisy PETAL Trial Hits on All Fronts
-
Piper Jaffray Downgrades UQM Technologies (UQM) to Neutral; New Customers Proving Elusive
-
DreamWorks (DWA) Shares Sink as 'Shrek Forever After' Weekend Sales Disappoint
-
Piper Jaffray & Co. (PJC) Fined $700K from the FINRA Regarding Email Retention Failure
-
Piper Jaffray Says Street Estimates for iPad May Be Getting Ahead of Supply (AAPL)
-
ReachLocal (RLOC) IPO Trades Higher
-
Piper Jaffray Maintains Positive Stance On Impax (IPXL)
-
Piper Jaffray Lifts Target On PetsMart (PETM) After Q1, But Still Neutral-Rated
-
Piper Jaffray Lifts Price Target On Limited Brands (LTD) to $30
-
Piper Jaffray Maintains Positive Stance On UPS (UPS) After Pilot Furloughs
-
Piper Jaffray Initiates Coverage on Tengion (TNGN) with an Overweight; Cutting-Edge Regenerative Medicine Play
-
Vitamin Shoppe (VSI) Prices 6.24M Common Offering at $23.50/Share
